Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung × lifastuzumab vedotin × Clear all

NCT01363947 2017-06-07

Safety and Pharmacokinetics of Escalating Doses of DNIB0600A in Participants With Non-Small Cell Lung Cancer (NSCLC) and Platinum Resistant Ovarian Cancer

Phase 1 Completed

GynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms